(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.23%) $83.66
(-1.16%) $1.619
(0.10%) $2 349.60
(-0.07%) $27.52
(0.25%) $924.40
(0.36%) $0.935
(0.67%) $11.02
(0.14%) $0.800
(-0.07%) $92.11
Quarter results tomorrow
(bmo 2024-04-29)
Expected move: +/- 4.93%
Live Chart Being Loaded With Signals
IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company offers active pharmaceutical ingredients (API), such as ibuprofen, ibuprofen lysinate, ibuprofen sodium, and dex- ibuprofen; and other APIs, including metformin hydrochloride, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, lamotrigine, and fenofibrate...
Stats | |
---|---|
Šios dienos apimtis | 175 174 |
Vidutinė apimtis | 456 235 |
Rinkos kapitalizacija | 23.45B |
EPS | INR0 ( 2024-04-26 ) |
Kita pelno data | ( INR0 ) 2024-04-29 |
Last Dividend | INR4.00 ( 2023-02-17 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 13.68 |
ATR14 | INR0.353 (0.09%) |
Tūris Koreliacija
IOL Chemicals and Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
SHIVALIK.NS | 0.882 |
KRSNAA.NS | 0.842 |
NESTLEIND.NS | 0.831 |
GANECOS.NS | 0.83 |
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
IOL Chemicals and Koreliacija - Valiuta/Žaliavos
IOL Chemicals and Finansinės ataskaitos
Annual | 2022 |
Pajamos: | INR22.17B |
Bruto pelnas: | INR6.70B (30.22 %) |
EPS: | INR23.70 |
FY | 2022 |
Pajamos: | INR22.17B |
Bruto pelnas: | INR6.70B (30.22 %) |
EPS: | INR23.70 |
FY | 2022 |
Pajamos: | INR21.68B |
Bruto pelnas: | INR5.72B (26.37 %) |
EPS: | INR28.56 |
FY | 2021 |
Pajamos: | INR19.46B |
Bruto pelnas: | INR8.22B (42.24 %) |
EPS: | INR76.21 |
Financial Reports:
No articles found.
IOL Chemicals and Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0 (N/A) |
INR0 (N/A) |
INR4.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR3.00 | 2020-03-18 |
Last Dividend | INR4.00 | 2023-02-17 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | INR17.00 | -- |
Avg. Dividend % Per Year | 0.77% | -- |
Score | 1.86 | -- |
Div. Sustainability Score | 3.29 | |
Div.Growth Potential Score | 3.37 | |
Div. Directional Score | 3.33 | -- |
Year | Amount | Yield |
---|---|---|
2020 | INR7.00 | 4.09% |
2021 | INR2.00 | 0.27% |
2022 | INR4.00 | 0.84% |
2023 | INR4.00 | 1.10% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SILINV.NS | Dividend Junior | 2023-08-18 | Annually | 23 | 0.63% | |
MBAPL.NS | Dividend Junior | 2023-09-18 | Annually | 8 | 0.44% | |
GUJAPOLLO.NS | Ex Dividend Junior | 2023-09-22 | Annually | 18 | 0.48% | |
BAYERCROP.NS | Dividend Junior | 2023-08-03 | Annually | 15 | 1.25% | |
PREMIERPOL.NS | Dividend Junior | 2023-09-11 | Sporadic | 9 | 0.39% | |
KAMDHENU.NS | Dividend Junior | 2023-08-14 | Sporadic | 17 | 0.32% | |
EDELWEISS.NS | Dividend Junior | 2023-09-18 | Annually | 17 | 2.38% | |
ADSL.NS | Dividend Junior | 2023-08-10 | Sporadic | 16 | 0.91% | |
STERTOOLS.NS | Dividend Junior | 2023-09-11 | Annually | 19 | 0.38% | |
NAHARCAP.NS | No Dividend Player | 2023-09-08 | Annually | 17 | 0.70% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0774 | 1.500 | 8.45 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.111 | 1.500 | 9.88 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 13.77 | 1.000 | 6.01 | 6.01 | [3 - 30] |
operatingCashFlowPerShareTTM | 19.96 | 2.00 | 3.35 | 6.69 | [0 - 30] |
freeCashFlowPerShareTTM | 19.96 | 2.00 | 0.0197 | 0.0394 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.345 | 1.000 | 7.59 | 7.59 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.109 | 1.000 | 9.82 | 9.82 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 3.29 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 13.67 | 1.000 | 8.72 | 0 | [1 - 100] |
returnOnEquityTTM | 0.111 | 2.50 | 9.92 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 19.96 | 2.00 | 3.35 | 0.0394 | [0 - 30] |
dividendYielPercentageTTM | 1.252 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 19.96 | 2.00 | 3.35 | 6.69 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.219 | 1.500 | -4.79 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0529 | 1.000 | -1.178 | 0 | [0.1 - 0.5] |
Total Score | 3.37 |
IOL Chemicals and
IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company offers active pharmaceutical ingredients (API), such as ibuprofen, ibuprofen lysinate, ibuprofen sodium, and dex- ibuprofen; and other APIs, including metformin hydrochloride, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, lamotrigine, and fenofibrate. Its products are used for treatments, which include anti-inflammatory, analgesic and antipyretic, anti-diabetic, anti- platelet, anti-cholesterol, anti- convulsant, anti-cholelithic, as well as proton pump inhibitor. The company also provides specialty industrial chemicals comprising ethyl acetate, iso butyl benzene, acetyl chloride, and mono chloro acetic acid for use in food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates industries. IOL Chemicals and Pharmaceuticals Limited was incorporated in 1986 and is headquartered in Ludhiana, India.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.